Disease | retinopathy, diabetic |
Comorbidity | C0730285|diabetic macular edema |
Sentences | 6 |
PubMedID- 24978668 | Conclusion: we demonstrated a significantly reduced sensitivity in both nonproliferative diabetic retinopathy groups without diabetic macular edema compared with healthy controls; this reduction was greater in type 2 diabetic patients. |
PubMedID- 23807186 | Purpose: to evaluate whether intravitreal ranibizumab injection at cataract surgery prevents postoperative diabetic macular edema (pme) in patients with stable diabetic retinopathy without significant macular edema. |
PubMedID- 22279402 | Posterior segment examination [figures 1 and 2] showed mild nonproliferative diabetic retinopathy without diabetic macular edema and a normal looking optic disc od with a small cup-to-disc (cd) ratio (0.1). |
PubMedID- 24349522 | In this study, we introduce choroidal area (ca; µm2) as a new parameter for analyzing choroidal quantity by edi sd-oct. ca can be used to interpret the choroidal factors that contribute to smd in non-proliferative diabetic retinopathy (npdr) patients with diabetic macular edema (dme). |
PubMedID- 22667326 | Results: indications for injection included age-related macular degeneration (69.7%), diabetic macular edema (13.3%), neovascularization due to proliferative diabetic retinopathy (6.9%), and cystoid macular edema secondary to retinal vascular occlusions (10.1%). |
PubMedID- 20535227 | Background: diabetic macular edema (dme) is one of the manifestations of diabetic retinopathy leading to loss of central vision and visual acuity. |
Page: 1